Literature DB >> 10408787

Comprehensive TP53-denaturing gradient gel electrophoresis mutation detection assay also applicable to archival paraffin-embedded tissue.

V M Hayes1, W Bleeker, E Verlind, T Timmer, A Karrenbeld, J T Plukker, M P Marx, R M Hofstra, C H Buys.   

Abstract

A comprehensive mutation detection assay is described for the entire coding region and all splice site junctions of TP53. The assay is based on denaturing gradient gel electrophoresis, which follows either multiplex polymerase chain reaction (PCR) applied to DNA extracted from fresh or frozen tissue samples or nested PCR applied to DNA extracted from paraffin-embedded tissue samples. In both instances, the analysis can be performed under a single set of conditions. When testing the assay on DNA from cultured lung cancer cell lines and from paraffin-embedded Dukes C colorectal carcinomas, significant TP53 mutations were observed at high frequencies in 15 of 16 lung cancer cell lines (94%) and in 21 of 30 paraffin-embedded tissue samples of Dukes C colorectal carcinomas (70%). A substantial proportion of these significant mutations occurred outside the evolutionary conserved region of TP53 in 4 of 16 lung cancer cell lines (25%) and in 11 of 30 paraffin-embedded colorectal carcinomas (37%). This underscores the importance of a comprehensive TP53 mutation analysis in those instances that TP53 mutation is taken into account for diagnostic and prognostic purposes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408787     DOI: 10.1097/00019606-199903000-00002

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  6 in total

1.  Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

Authors:  M A Adank; E Brogi; F Bogomolniy; E A Wadsworth; K J Lafaro; C J Yee; T Kirchhoff; E J Meijers-Heijboer; N D Kauff; J Boyd; K Offit
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

2.  Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.

Authors:  Shih-Jen Hwang; Guillermina Lozano; Christopher I Amos; Louise C Strong
Journal:  Am J Hum Genet       Date:  2003-02-27       Impact factor: 11.025

Review 3.  Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.

Authors:  Nayiri M Kaissarian; Douglas Meyer; Chava Kimchi-Sarfaty
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

4.  Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q.

Authors:  Ronald Boonstra; Alice Koning; Mirjam Mastik; Anke van den Berg; Sibrand Poppema
Journal:  Virchows Arch       Date:  2003-06-12       Impact factor: 4.064

Review 5.  The p53 mRNA: an integral part of the cellular stress response.

Authors:  Lucia Haronikova; Vanesa Olivares-Illana; Lixiao Wang; Konstantinos Karakostis; Sa Chen; Robin Fåhraeus
Journal:  Nucleic Acids Res       Date:  2019-04-23       Impact factor: 16.971

Review 6.  Translational Control in p53 Expression: The Role of 5'-Terminal Region of p53 mRNA.

Authors:  Agata Swiatkowska; Mariola Dutkiewicz; Paulina Zydowicz-Machtel; Joanna Szpotkowska; Damian M Janecki; Jerzy Ciesiołka
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.